A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine

Details for Australian Patent Application No. 2002224815 (hide)

Owner Akzo Nobel N.V.

Inventors Koolen, Marcus Josephus Marie; Mebatsion, Teshome

Agent Spruson & Ferguson

Pub. Number AU-B-2002224815

PCT Pub. Number WO02/36617

Priority 00203814.9 02.11.00 EP

Filing date 30 October 2001

Wipo publication date 15 May 2002

Acceptance publication date 12 October 2006

International Classifications

C07K 14/125 (2006.01) Peptides having more than 20 amino acids

Event Publications

12 October 2006 Application Accepted

  Published as AU-B-2002224815

16 November 2006 Assignment before Grant

  Akzo Nobel N.V. The application has been assigned to Intervet International B.V.

8 February 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002224816-Brazing product having a low melting point

2002224814